HOME >> BIOLOGY >> NEWS
Cutting The Time And Cost Of Developing New Cures: Lord Sainsbury Launches World's First Biomedical Accelerator Mass Spectrometer In York

The first Accelerator Mass Spectrometer (AMS) in the world to be dedicated to biomedical research is launched officially today (23 November) by Lord Sainsbury, the Minister for Science at CBAMS Ltd.

Identifying promising drugs that could lead to life saving cures in the future can take eight to ten years and cost as much as 200 million. The AMS can investigate large numbers of drugs for pharmaceutical companies, significantly speeding up drug development by quickly identifying the most promising. In some cases it may cut development time by up to six months. With new drugs earning 1 million per day the appeal of using the AMS is obvious. The technique, which is based on carbon dating used to measure the age of ancient finds, will be between one hundred thousand and one million times more sensitive than traditional methods.

"For the first time, pharmaceutical and other biomedical research companies all over the world can access a technique which will speed up drug investigations significantly," said Professor Colin Garner, chief executive officer of CBAMS Ltd. "The technique will also make such investigations safer."

Lord Sainsbury said: "This initiative is a landmark for UK science and reinforces York's position as an important centre for scientific expertise, with a reputation for excellence, initiative and endeavour that is admired internationally."

The AMS is located at the Central Science Laboratory at Sand Hutton, York, and is operated by CBAMS Ltd (the Centre for Biomedical Accelerator Mass Spectrometry), a subsidiary company of the University of York. The machine was purchased with guaranteed contracts for research projects from Glaxo Wellcome, Pfizer, Novartis and Janssen Pharmaceutica.

"CBAMS is a prime example of the sort of start-up company which will be encouraged under the Science City York project," commented Professor Ron Cooke, Vice-Chancellor of the University of York. "CBAMS has worked closely with potential customers
'"/>

Contact: Professor Colin Garner
colin.garner@cbams.co.uk
44-1904-462700
University of York
20-Nov-1998


Page: 1 2

Related biology news :

1. Cutting-edge cancer researchers sought for international recognition
2. Cutting back on cigarettes: when less is more
3. AChemS: Cutting edge research in taste, smell, & chemical irritation
4. Cutting edge
5. Cutting-edge research to be presented at ASCPT pharmacology conference
6. Cutting the risk of coronary disease - start before birth says UK doctor
7. Story Tips: Engineering Students Pursue Cutting-Edge Research
8. Brain Building May Depend On DNA Cutting And Pasting
9. Flexibility In Cutting Toxic Releases Yields Dividends
10. Gene Shears In Cutting Edge Anti-Aids Trial
11. Developing tools for reliable gene chip measurements

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/27/2020)... , ... January 27, 2020 , ... On Thursday, February ... Solutions Life Sciences, Reed Tech and Richard Castle, Global Account Manager Medical ... discussing the procedure, other topics include EU MDR timing deadlines, best practices in creating ...
(Date:1/24/2020)... ... January 24, 2020 , ... Shoreline Biome , ... strain level, today announced that the company will debut a novel new DNA isolation ... , The new product, Shoreline Biome's Rapid Prep kit, is a fast and easy-to-use ...
(Date:1/24/2020)... (PRWEB) , ... January 24, 2020 , ... Worldwide ... Technology President Dr. Stanley Stanbridge and Vice President of Sales and Marketing Jeff ... Fox Business Network as sponsored content on Sunday, Jan. 26, 2020 at 5:30 p.m. ...
Breaking Biology News(10 mins):
(Date:1/27/2020)... ... 27, 2020 , ... Valencell, the leading innovator in wearable ... by Halma plc , a FTSE 100 global group of life-saving technology ... WSJ Joshua Fund. A representative from Halma will join the Valencell board of ...
(Date:1/23/2020)... , ... January 22, 2020 , ... ... developments in the cosmetic surgery industry at two recent North American investor forums ... at the Canaccord Genuity Medical Technologies & Diagnostics Forum on November 21, 2019 ...
(Date:1/22/2020)... , ... January 21, 2020 , ... QCDx , ... biopsy from a simple blood draw, today announced the sale of the proprietary RareScope™ ... Rare Scope will be used in clinical cancer research. , “The RareScope can detect ...
(Date:1/8/2020)... ... January 08, 2020 , ... Anomet Products ... properties for use in harsh environments inside or outside of the human body. ... metals or alloys to achieve specific properties such as corrosion-resistance, biocompatibility, or operation ...
Breaking Biology Technology:
Cached News: